For: | Xing LL, Wang ZN, Jiang L, Zhang Y, Xu YY, Li J, Luo Y, Zhang X. Matrix metalloproteinase-9-1562C>T polymorphism may increase the risk of lymphatic metastasis of colorectal cancer. World J Gastroenterol 2007; 13(34): 4626-4629 [PMID: 17729419 DOI: 10.3748/wjg.v13.i34.4626] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v13/i34/4626.htm |
Number | Citing Articles |
1 |
B. Peng, L. Cao, X. Ma, W. Wang, D. Wang, L. Yu. Meta-analysis of association between matrix metalloproteinases 2, 7 and 9 promoter polymorphisms and cancer risk. Mutagenesis 2010; 25(4): 371 doi: 10.1093/mutage/geq015
|
2 |
Zhihai Teng, Song Wang, Hao Yuan, Hu Wang, Jingdong Li, Xueliang Chang, Yanping Zhang, Zhenwei Han, Yaxuan Wang.
MMP-9
gene polymorphisms on cancer risk: an updated systematic review and meta-analysis
. Nucleosides, Nucleotides & Nucleic Acids 2024; : 1 doi: 10.1080/15257770.2023.2299710
|
3 |
Janusz K. Rybakowski. Matrix Metalloproteinase-9 (MMP9)—A Mediating Enzyme in Cardiovascular Disease, Cancer, and Neuropsychiatric Disorders. Cardiovascular Psychiatry and Neurology 2009; 2009: 1 doi: 10.1155/2009/904836
|
4 |
Brigita Glebauskiene, Rasa Liutkeviciene, Alvita Vilkeviciute, Loresa Kriauciuniene, Silvija Jakstiene, Egle Zlatkute, Abdonas Tamosiunas, Reda Zemaitiene, Paulina Vaitkiene, Dalia Zaliuniene. Does MMP-9 Gene Polymorphism Play a Role in Pituitary Adenoma Development?. Disease Markers 2017; 2017: 1 doi: 10.1155/2017/5839528
|
5 |
Li-Feng Zhang, Yuan-Yuan Mi, Qiang Cao, Wei Wang, Chao Qin, Jun-Feng Wei, Yao-Jun Zhou, Yong-Fei Li, Min Tang, Wei-Min Liu, Wei Zhang, Jian-Gang Zou. Update analysis of studies on the MMP-9 −1562 C>T polymorphism and cancer risk. Molecular Biology Reports 2012; 39(4): 3435 doi: 10.1007/s11033-011-1115-5
|
6 |
Atul Katarkar, Chandraday Prodhan, Sanjit Mukherjee, Jay G. Ray, Keya Chaudhuri. Role of matrix metalloproteinase-9 polymorphisms in basement membrane degradation and pathogenesis of oral submucous fibrosis. Meta Gene 2018; 16: 255 doi: 10.1016/j.mgene.2018.04.001
|
7 |
Naglaa Raafat AbdRaboh, Fatehia Ali Bayoumi. Gene polymorphism of matrix metalloproteinases 3 and 9 in breast cancer. Gene Reports 2016; 5: 151 doi: 10.1016/j.genrep.2016.10.007
|
8 |
Ajaikumar B. Kunnumakkara, Parmeswaran Diagaradjane, Preetha Anand, Harikumar B. Kuzhuvelil, Amit Deorukhkar, Juri Gelovani, Sushovan Guha, Sunil Krishnan, Bharat B. Aggarwal. Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX‐2, MMP‐9, VEGF and CXCR4 expression in an orthotopic mouse model. International Journal of Cancer 2009; 125(9): 2187 doi: 10.1002/ijc.24593
|
9 |
Kyung Sook Park, Seon Jeong Kim, Kyung Ho Kim, Jin Cheon Kim. Clinical characteristics of TIMP2, MMP2, and MMP9 gene polymorphisms in colorectal cancer. Journal of Gastroenterology and Hepatology 2011; 26(2): 391 doi: 10.1111/j.1440-1746.2010.06504.x
|
10 |
Sugreev Verma, Kousik Kesh, Arnab Gupta, Snehasikta Swarnakar. An Overview of Matrix Metalloproteinase 9 Polymorphism and Gastric Cancer Risk. Asian Pacific Journal of Cancer Prevention 2015; 16(17): 7393 doi: 10.7314/APJCP.2015.16.17.7393
|
11 |
Ajay Kumar Chaudhary, Shruti Pandya, Kanjaksha Ghosh, Anita Nadkarni. Matrix metalloproteinase and its drug targets therapy in solid and hematological malignancies: An overview. Mutation Research/Reviews in Mutation Research 2013; 753(1): 7 doi: 10.1016/j.mrrev.2013.01.002
|
12 |
Chaoliang Hu, Fangzhong Weng, Lin Li, Wei Dai, Jun Yan, Liqing Peng, Ruixiang Zhou. Association between MMP-9 −1562 C/T polymorphism and susceptibility to digestive cancers: A meta-analysis. Gene 2018; 673: 88 doi: 10.1016/j.gene.2018.06.025
|
13 |
Dan Liu, Wenyuan Duan, Hong Guo, Xueqing Xu, Yun Bai. Meta-analysis of associations between polymorphisms in the promoter regions of matrix metalloproteinases and the risk of colorectal cancer. International Journal of Colorectal Disease 2011; 26(9): 1099 doi: 10.1007/s00384-011-1198-4
|
14 |
Antonio Z. Gimeno-García, Javier Triñanes, Enrique Quintero, Eduardo Salido, David Nicolás-Pérez, Zaida Adrián-de-Ganzo, Onofre Alarcón-Fernández, Beatriz Abrante, Rafael Romero, Marta Carrillo, Laura Ramos, Inmaculada Alonso, Juan Ortega, Alejandro Jiménez. Plasma matrix metalloproteinase 9 as an early surrogate biomarker of advanced colorectal neoplasia. Gastroenterología y Hepatología 2016; 39(7): 433 doi: 10.1016/j.gastrohep.2015.10.002
|
15 |
Antonio Z. Gimeno-García, Javier Triñanes, Enrique Quintero, Eduardo Salido, David Nicolás-Pérez, Zaida Adrián-de-Ganzo, Onofre Alarcón-Fernández, Beatriz Abrante, Rafael Romero, Marta Carrillo, Laura Ramos, Inmaculada Alonso, Juan Ortega, Alejandro Jiménez. Plasma matrix metalloproteinase 9 as an early surrogate biomarker of advanced colorectal neoplasia. Gastroenterología y Hepatología (English Edition) 2016; 39(7): 433 doi: 10.1016/j.gastre.2016.06.015
|
16 |
Vivek R. Yadav, Sahdeo Prasad, Bokyung Sung, Juri G. Gelovani, Sushovan Guha, Sunil Krishnan, Bharat B. Aggarwal. Boswellic acid inhibits growth and metastasis of human colorectal cancer in orthotopic mouse model by downregulating inflammatory, proliferative, invasive and angiogenic biomarkers. International Journal of Cancer 2012; 130(9): 2176 doi: 10.1002/ijc.26251
|
17 |
Wen-Liang Fang, Wei-Bo Liang, Huan He, Yi Zhu, Shi-Liu Li, Lin-Bo Gao, Lin Zhang. Association of Matrix Metalloproteinases 1, 7, and 9 Gene Polymorphisms with Genetic Susceptibility to Colorectal Carcinoma in a Han Chinese Population. DNA and Cell Biology 2010; 29(11): 657 doi: 10.1089/dna.2010.1017
|
18 |
Guangfu Jin, Ruifen Miao, Zhibin Hu, Lin Xu, Xinen Huang, Yijiang Chen, Tian Tian, Qingyi Wei, Paolo Boffetta, Hongbing Shen. Putative functional polymorphisms of MMP9 predict survival of NSCLC in a Chinese population. International Journal of Cancer 2009; 124(9): 2172 doi: 10.1002/ijc.24190
|
19 |
Hong Zhi, Hua Wang, Liqun Ren, Zhiyang Shi, Haiyan Peng, Lunbiao Cui, Genshan Ma, Xingzhou Ye, Yi Feng, Chengxing Shen, Xiangjun Zhai, Chenyu Zhang, Ke Zen, Naifeng Liu. Functional polymorphisms of matrix metallopeptidase-9 and risk of coronary artery disease in a Chinese population. Molecular Biology Reports 2010; 37(1): 13 doi: 10.1007/s11033-009-9482-x
|
20 |
Ai-Lin Li, Xin Zhou, Zhen-Ning Wang, Yong-Xi Song, Peng Gao, Yuan Miao, Jin-Liang Zhu, Hui-Mian Xu. Associations of non-metastatic cells 1 gene polymorphisms with lymph node metastasis risk of gastric cancer in Northern Chinese population. Tumor Biology 2012; 33(6): 2159 doi: 10.1007/s13277-012-0476-2
|
21 |
XIAOMAN ZHANG, XINHUI CAO, XIAOYU XU, AIFAN LI, YUMING XU. Correlation between the −1562C/T polymorphism in the matrix metalloproteinase-9 gene and hemorrhagic transformation of ischemic stroke. Experimental and Therapeutic Medicine 2015; 9(3): 1043 doi: 10.3892/etm.2015.2186
|
22 |
Matej Horvat, Uroš Potočnik, Katja Repnik, Rajko Kavalar, Borut Štabuc. Single Nucleotide Polymorphisms as Prognostic and Predictive Factors of Adjuvant Chemotherapy in Colorectal Cancer of Stages I and II. Gastroenterology Research and Practice 2016; 2016: 1 doi: 10.1155/2016/2139489
|
23 |
Peter McColgan, Pankaj Sharma. Polymorphisms of matrix metalloproteinases 1, 2, 3 and 9 and susceptibility to lung, breast and colorectal cancer in over 30,000 subjects. International Journal of Cancer 2009; 125(6): 1473 doi: 10.1002/ijc.24441
|
24 |
Dan Liu, Hong Guo, Yafei Li, Xueqing Xu, Kang Yang, Yun Bai, Chunyan He. Association between Polymorphisms in the Promoter Regions of Matrix Metalloproteinases (MMPs) and Risk of Cancer Metastasis: A Meta-Analysis. PLoS ONE 2012; 7(2): e31251 doi: 10.1371/journal.pone.0031251
|
25 |
Mujeeb Zafar Banday, Aga Syed Sameer, Ashaq Hussain Mir, Taseem A. Mokhdomi, Nissar A. Chowdri, Ehtishamul Haq. Matrix metalloproteinase (MMP) -2, -7 and -9 promoter polymorphisms in colorectal cancer in ethnic Kashmiri population — A case–control study and a mini review. Gene 2016; 589(1): 81 doi: 10.1016/j.gene.2016.05.028
|
26 |
Francine Blei. Literature Watch. Lymphatic Research and Biology 2007; 5(4): 275 doi: 10.1089/lrb.2007.5402
|
27 |
Diana Schveigert, Konstantinas Povilas Valuckas, Viktorija Kovalcis, Albertas Ulys, Genovefa Chvatovic, Janina Didziapetriene. Significance of MMP-9 expression and MMP-9 polymorphism in prostate cancer. Tumori Journal 2013; 99(4): 523 doi: 10.1177/030089161309900414
|
28 |
Amal Ahmed Abd El-Fattah, Nermin Abdel Hamid Sadik, Olfat Gamil Shaker, Amal Mohamed Kamal. Single Nucleotide Polymorphism in SMAD7 and CHI3L1 and Colorectal Cancer Risk. Mediators of Inflammation 2018; 2018: 1 doi: 10.1155/2018/9853192
|
29 |
Abdelbaset Buhmeida, Riyad Bendardaf, Marja Hilska, Yrjö Collan, Matti Laato, Stina Syrjänen, Kari Syrjänen, Seppo Pyrhönen. Prognostic Significance of Matrix Metalloproteinase-9 (MMP-9) in Stage II Colorectal Carcinoma. Journal of Gastrointestinal Cancer 2009; 40(3-4) doi: 10.1007/s12029-009-9091-x
|
30 |
László Herszényi, István Hritz, Gábor Lakatos, Mária Varga, Zsolt Tulassay. The Behavior of Matrix Metalloproteinases and Their Inhibitors in Colorectal Cancer. International Journal of Molecular Sciences 2012; 13(10): 13240 doi: 10.3390/ijms131013240
|
31 |
Burcu Çaykara, Hani Alsaadoni, Sadrettin Pençe, Halime Hanım Pençe, Alper Ötünçtemur. Investigation of MMP-9 rs3918242 and TIMP-2 rs8179090 polymorphisms in renal cell carcinoma tissues. Turkish Journal of Biochemistry 2020; 45(4): 429 doi: 10.1515/tjb-2019-0048
|
32 |
Xiaoying Li, Lianxi Qu, Yu Zhong, Yingjie Zhao, Hongyan Chen, Lu Daru. Association between promoters polymorphisms of matrix metalloproteinases and risk of digestive cancers: a meta-analysis. Journal of Cancer Research and Clinical Oncology 2013; 139(9): 1433 doi: 10.1007/s00432-013-1446-9
|
33 |
Ajay Kumar Chaudhary, Shruti Pandya, Ravi Mehrotra, Mangal Singh, Mamta Singh. Role of functional polymorphism of matrix metalloproteinase-2 (-1306 C/T and -168 G/T) and MMP-9 (-1562 C/T) promoter in oral submucous fibrosis and head and neck squamous cell carcinoma in an Indian population. Biomarkers 2011; 16(7): 577 doi: 10.3109/1354750X.2011.609602
|
34 |
Alexandra MJ Langers, Hein W Verspaget, Daniel W Hommes, Cornelis FM Sier. Single-nucleotide polymorphisms of matrix metalloproteinases and their inhibitors in gastrointestinal cancer. World Journal of Gastrointestinal Oncology 2011; 3(6): 79-98 doi: 10.4251/wjgo.v3.i6.79
|